Samantha Dale Strasser

Today @pepper_bio and @G1Therapeutics announced an in-licensing deal for a liver cancer therapeutic. Identified via our COMPASS platform, this therapeutic has been shown to be more effective than current options. Read here @FierceBiotech: fiercebiotech.com/biotech/pepper…

Teasing out the combinatorics of cell signaling at massive scale is a key challenge in regenerative medicine — and central to fundamental questions in developmental biology. Last week, our Scientific Co-Founder Olivier Pourquié presented at @KeystoneSymp on Stem Cell Models in Embryology, sharing new data from his lab on the regulation of the segmentation clock – a vivid demonstration of how much combinatorial signaling has to teach us about the logic of development. It's exactly this that points to where the field is heading: at Cellular Intelligence, we've built the capabilities to tackle this at unprecedented scale — massively multiplexed signaling in encapsulated PSCs, exposing cells to millions of experimental conditions and unlocking a foundation model to predict cell signaling responses. It's a bold vision for what's possible when developmental biology meets AI-driven discovery — one that puts us on a path to truly understand, predict, and ultimately control cell fate.

What will AI never replace? Closing deals - the human moment when someone decides to bet on you. Honored to share my answer to this thought provoking question alongside other leaders in Entrepreneur Magazine: entrepreneur.com/building-a-bus… cc @Entrepreneur @FrancesDodds1 @aribloom

“Linear effort, exponential scale.” @JShendure perfectly captures why we built Cellular Intelligence. We aren’t just running experiments, we’re turning biology into a predictive engineering discipline. When you have a team like this, the “impossible” (@arjunrajlab) starts to look like a roadmap. Incredibly proud of this team. cellularintelligence.com More next week on how this mission comes to life. #CellularIntelligence #TechBio

At Cellular Intelligence, we are making the impossible possible. Others conduct one experiment per day, 300 days a year. That’s roughly 6,000 experiments over 20 years. We ran 75,000 experiments in just 9 days. In other words, we run more experiments in a single day than many leading labs can complete over 20 years. This is a turning point for understanding cell signaling that could unlock new ways to treat the many incurable diseases humans face today. Stay tuned to learn more about how we’re making this come to life: cellularintelligence.com cc @JShendure

Modern biology struggles to predict and control cellular behavior because cell signaling is complex and context-dependent. To solve this, we are building the first universal virtual cell-signaling model. Read our recent white paper to learn more: cellularintelligence.com/science

One of those rare evenings where the room goes quiet because the implications are huge. Hear from Jacob Petersen + @JShendure on why predictive cell biology could change the future of drug discovery and regenerative medicine. Follow @CellularIntelHQ as we share more insights from other scientific luminaries such as Jacob and Jay throughout the month: cellularintelligence.com

We are building a future where biology is no longer destiny, but design. At Cellular Intelligence, we’re creating what has never existed: a way to predict, model, and control how cells behave before experiments are ever run. By combining large-scale cellular data with AI, we’re decoding the rules of cell signaling and turning biology from an observational science into predictive engineering. Follow along as we share more insights throughout the month, and discover why this moment could change the future of drug discovery and regenerative medicine: cellularintelligence.com cc @JShendure

Thank you @BiotechTV for hosting me - what a great way to cap an exhilarating week at #JPM26 with the Cellular Intelligence team. I spoke with @RS_Flinn about how at @CellularIntelHQ we’re generating massive, time-resolved datasets and training foundation models to predict - and ultimately control - cellular behavior. This isn’t incremental. It’s foundational - and it’s how we achieve an AlphaFold moment for developmental biology, unlocking breakthroughs across disease modeling, drug discovery, and regenerative medicine. Watch the full conversation here: bit.ly/45CerC8

How do you teach AI the language of cells? Our CEO, @MichaBreakstone, explains on @BiotechTV how Cellular Intelligence is generating massive, time-resolved data and training foundation models to predict - and ultimately control - cellular behavior, transforming disease modeling, drug discovery, and regenerative medicine. Thanks @BiotechTV and @RS_Flinn for the thoughtful conversation. bit.ly/45CerC8

The new year marks a new era: Somite is now Cellular Intelligence. This is a statement of what we are building: the first universal virtual cell signaling-model to understand, predict, and control cell behavior. To mark this moment, we’re releasing a white paper sharing technical milestones and our roadmap for the future: cellularintelligence.com/science Learn more about the future we are building – where biology is no longer destiny, but design: cellularintelligence.com

It’s been a remarkable summer at Somite: our labs and offices have been overflowing with scientific energy. We’ve had the privilege of hosting Olivier Pourquié (@harvardmed) , Allon Klein (@harvardmed, @KleinLabHMS), and Arjun Raj (@upenn, @arjunrajlab) on sabbatical - each bringing not only their expertise, but also their creativity, curiosity, and passion for building the future of cell therapies. 🚀

@SomiteAi × AMD Ventures: Boosting Compute to Reimagine Cell Therapies! Thrilled to announce a strategic investment from @AMD Ventures, following our Series A led by @KhoslaVentures. Pairing our data engine with AMD Instinct GPUs helps build the compute stack for the next generation of cell therapies. 🔗 bit.ly/3JFsMW2

90 seconds that capture the future of medicine. See the energy from our new Boston lab and Series A launch. Watch now @SomiteAI #AI #StemCells #FutureOfMedicine

Catch the energy of our recent Boston lab-warming and Series A celebration. Our CEO @MichaBreakstone shares a highlights video capturing Somite's vision for the future of medicine. Watch below! #AI #StemCells #FutureOfMedicine #Boston

Somite named one of Israel’s 15 most promising startups for 2025! 🚀 Huge thanks to @TheMarker for the recognition - past honorees include unicorns like @Hailo_ai , @Gong_io, @Papaya_Global, & @viz_ai. Click below for the full story 👇 bit.ly/4lz05aC

Such a dream to be making waves that are featured on @FierceBiotech !

🧬Thank you @HealthTechX for selecting Pepper Bio as a finalist in the Innovator category! We’re dedicated to making ‘untreatable diseases’ a thing of the past. Congrats to our fellow finalists!

@POLITICO discusses @NIH's move towards animal testing alternatives. @SamanthaDStrass explains the FDA catalyst shifting focus from animal models to computational methods for more accurate and cost-effective outcomes bit.ly/3SYa8v7

Energized by @pepper_bio's feature in @TechCrunch's Pitch Deck Teardown! @Haje's review of our $6.5M seed pitch highlights our mission to treat untreatable diseases. Haje’s praise of our market size slide reflects our areas of commitment bit.ly/3tGM31X